NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

I don't see anything negative in the authors' reluctance to pass judgement on a trial that has yet to come out with the final results.

Am I missing something?

meirluc,

Marjolein Geurts, one of the authors, has worked as a research fellow in The James Comprehensive Cancer Center at The Ohio State University (Columbus, Ohio; supervisor, Dr. Arnab Chakravarti).
And the Ohio State University Columbus, Ohio, United States is one of the 86 trial locations in our DCVax-L trial.
That could be a positive!

From an older paper:

Marjolein Geurts will complete her neurology residency in January 2019. She works at the University Medical Center Utrecht. During her residency, she strongly focused on neuro-oncology. She has performed a clinical specialization in the Brain Tumor Center at Erasmus Medical Center Cancer Institute (Rotterdam, The Netherlands; supervisor, Professor Martin J. van den Bent) and has worked as a research fellow in The James Comprehensive Cancer Center at The Ohio State University (Columbus, Ohio; supervisor, Dr. Arnab Chakravarti). In addition to her laboratory work, which focuses on microRNAs in glioblastoma, she is also interested in clinical research.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587541/

https://clinicaltrials.gov/ct2/show/NCT00045968